The Stress Urinary Incontinence Device Market is expected to grow at an 5.5 % CAGR during the forecast period for 2023-2031.
Stress Urinary Incontinence (SUI) is the involuntary leakage of urine during activities that upsurge pressure inside the abdomen and push down on the bladder, such as coughing, sneezing, running, or heavy lifting. There are numerous sources of SUI which comprise pregnancy, childbirth (particularly where forceps were needed), weight gain, and chronic straining or coughing. Multiple devices such as Vaginal inserts, including incontinence pessaries and incontinence tampons are designed to prevent urinary leakage, usually for women with stress urinary incontinence (SUI).
Augmented in geriatric population, huge pool of women showing early symptoms of menopause, growing cases of hysterectomy is expected to be one of the prominent factors driving the market growth. The market is further expected to grow at a significant rate owing to features such as rising number of investments in health care, escalating awareness, and expanding number of obese populations. The cumulative occurrence of smoking in women are expected to play a key role in promoting market growth over the next few years.
Market Segmentation
The Global Stress Urinary Incontinence Device market is categorized on the basis of product, end-user and region. On the basis of product type, the market is segmented into Sling Systems, Vaginal Pessary Devices, Artificial Urinary Sphincter (AUS), Pelvic Floor Muscle Stimulator, and Injectable Urethral Bulking Agents/Injections. On the basis of end-user, the market is segmented into Hospitals, Gynecological Clinics, and Homecare Settings. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some of The Key Players in The Stress Urinary Incontinence Device Market:
- Coloplast A/S
- Contura Ltd.
- Elidah, Inc.
- Laborie, Inc. (Cogentix Medical)
- Atlantic Therapeutic
- Boston Scientific Corporation,
- Johnson & Johnson Services. Inc.
- BD
- CooperSurgical, Inc.
- MEDGYN PRODUCTS, INC.
- Cousin Biotech
- Caldera Medical
- Betatech Medical
- FEG Textiltechnik mbH.
- Affluent Medical
- pfm medical ag
- Betatech Medical
- Caldera Medical Inc
- Neomedic International
- EUROMED
- Zephyr Surgical Implants
- Viveve Medical, Inc.
- UroMems
- Other Prominent Players
The Stress Urinary Incontinence Device Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 5.5 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Coloplast A/S, Contura Ltd., Laborie, Inc. (Cogentix Medical), Atlantic Therapeutics, Boston Scientific Corporation, Johnson & Johnson Services. Inc., BD, CooperSurgical, Inc., MEGYN PRODUCTS, INC., Cousin Biotech, Caldera Medical, Betatech Medical, FEG Textiltechnik mbH, Affluent Medical, pfm medical ag, Betatech Medical, Caldera Medical Inc., Neomedic International, EUROMED, Zephyr Surgical Implants, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
